BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32278688)

  • 21. Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells.
    Feldman DE; Chen C; Punj V; Tsukamoto H; Machida K
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):829-34. PubMed ID: 22207628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.
    Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P
    Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and Characterization of Human Colon Adenocarcinoma Stem-Like Cells Based on the Endogenous Expression of the Stem Markers.
    Koshkin SA; Anatskaya OV; Vinogradov AE; Uversky VN; Dayhoff GW; Bystriakova MA; Pospelov VA; Tolkunova EN
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell markers in glioma progression and recurrence.
    Hattermann K; Flüh C; Engel D; Mehdorn HM; Synowitz M; Mentlein R; Held-Feindt J
    Int J Oncol; 2016 Nov; 49(5):1899-1910. PubMed ID: 27600094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Putative cancer stem cells are present in surgical margins of oral squamous cell carcinoma.
    Lazarevic M; Milosevic M; Trisic D; Toljic B; Simonovic J; Nikolic N; Mikovic N; Jelovac D; Petrovic M; Vukadinovic M; Milasin J
    J BUON; 2018; 23(6):1686-1692. PubMed ID: 30610795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
    Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
    Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
    Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
    Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
    Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquisition of tumorigenic potential and enhancement of angiogenesis in pulmonary stem/progenitor cells through Oct-4 hyperexpression.
    Gu SY; Ho CC; Huang YK; Chen HW; Wang YC; Kuo CY; Teng SC; Fu WM; Yang PC; Wu CW; Peng FC; Ling TY
    Oncotarget; 2016 Mar; 7(12):13917-31. PubMed ID: 26871601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OCT4&SOX2-specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem-like cells in vitro and treating drug-resistant lung cancer mice in vivo.
    Zhang X; Hu F; Li C; Zheng X; Zhang B; Wang H; Tao G; Xu J; Zhang Y; Han B
    J Cell Physiol; 2019 May; 234(5):6758-6768. PubMed ID: 30382588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma.
    Martins Balbinot K; Almeida Loureiro FJ; Chemelo GP; Alves Mesquita R; Cruz Ramos AMP; Ramos RTJ; da Costa da Silva AL; de Menezes SAF; da Silva Kataoka MS; Alves Junior SM; Viana Pinheiro JJ
    PeerJ; 2023; 11():e14349. PubMed ID: 36655039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCL-X
    Trisciuoglio D; Tupone MG; Desideri M; Di Martile M; Gabellini C; Buglioni S; Pallocca M; Alessandrini G; D'Aguanno S; Del Bufalo D
    Cell Death Dis; 2017 Dec; 8(12):3216. PubMed ID: 29238043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colon adenocarcinoma-derived cells that express induced-pluripotent stem cell markers possess stem cell function.
    Munro MJ; Peng L; Wickremesekera SK; Tan ST
    PLoS One; 2020; 15(5):e0232934. PubMed ID: 32428045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Microenvironmental Change by B16F10 Melanoma-derived Proteins Induces Cancer Stem-like Cell Properties from NIH3T3 Cells.
    Park SY; Lee DG; Jo A; Choi H; Lee JE; Jeong AJ; Leem SH; Jun W; Shim S; Ye SK; Min JK; Chung JW
    Sci Rep; 2019 Nov; 9(1):16757. PubMed ID: 31727938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone is increased in the lungs and enhances experimental lung metastasis of melanoma in DJ-1 KO mice.
    Chien CH; Lee MJ; Liou HC; Liou HH; Fu WM
    BMC Cancer; 2016 Nov; 16(1):871. PubMed ID: 27825319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy.
    Jia Q; Yang F; Huang W; Zhang Y; Bao B; Li K; Wei F; Zhang C; Jia H
    Theranostics; 2019; 9(2):424-435. PubMed ID: 30809284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4.
    Long W; Zhao W; Ning B; Huang J; Chu J; Li L; Ma Q; Xing C; Wang HY; Liu Q; Wang RF
    J Mol Cell Biol; 2018 Apr; 10(2):147-160. PubMed ID: 29452418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Merlin in B16F10 mouse melanoma cells reduces their metastatic activity: role of the cell surface heparan sulfate glycosaminoglycans.
    Galcheva-Gargova Z; Zhidkova N; Geisler S; Ozug J; Wudyka S; Gunay NS; Qi YW; Shriver Z; Venkataraman G
    Int J Oncol; 2008 Jun; 32(6):1237-43. PubMed ID: 18497985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.